Amgen Files NDA, Seeks FDA Approval For Parathyroid Drug
August 25, 2015 at 20:49 PM EDT
Amgen shares end the day down 1% after filing an NDA for its intravenous drug etelcalcetide.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
